Variantyx Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
194
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$2.5M
- Investors
-
11
Variantyx General Information
Description
Developer of genetic testing platforms designed to improve diagnosis and personalised medicine for rare genetic disorders, reproductive genetics and precision oncology. The company's platform features advanced laboratory technology, proprietary AI and machine learning analytical tools, flexible reflex testing options, and streamlined patient billing policies, enabling healthcare providers and patients to access detailed genomic analysis that supports clinical decision-making and shortens the diagnostic process.
Contact Information
Website
www.variantyx.comCorporate Office
- 1671 Worcester Road
- Suite 400
- Framingham, MA 01701
- United States
Corporate Office
- 1671 Worcester Road
- Suite 400
- Framingham, MA 01701
- United States
Variantyx Timeline
Variantyx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series D) | 01-Apr-2025 | $2.5M | Completed | Generating Revenue | ||
| 9. Later Stage VC (Series D) | 26-Apr-2024 | Completed | Generating Revenue | |||
| 8. Debt - General | 18-Oct-2022 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C2) | 14-Feb-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 15-Nov-2021 | Completed | Generating Revenue | |||
| 5. Debt - PPP | 02-May-2020 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 20-Mar-2020 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 29-May-2019 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 28-Dec-2018 | $4.8M | $4.8M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2014 | Completed | Startup |
Variantyx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series D-2 | ||||||||
| Series D-1 | ||||||||
| Series C-2 | ||||||||
| Series C-1 | ||||||||
| Series C | ||||||||
| Series B | 6,206,645 | $0.010000 | $1.37 | $1.37 | 1x | $1.37 | 4.64% | |
| Series A | 3,709,246 | $0.010000 | $1.31 | $1.31 | 1x | $1.31 | 2.78% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Variantyx Comparisons
Industry
Financing
Details
Variantyx Competitors (19)
One of Variantyx’s 19 competitors is Igenomix, a Formerly PE-Backed company based in Miami, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Igenomix | Formerly PE-Backed | Miami, FL | ||||
| BGI Genomics | Formerly VC-backed | Shenzhen, China | ||||
| Caris Life Sciences | Formerly PE-Backed | Irving, TX | ||||
| Personalis | Formerly VC-backed | Fremont, CA | ||||
| Novogene | Formerly VC-backed | Beijing, China |
Variantyx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Variantyx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Variantyx Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Peregrine Ventures | Venture Capital | Minority | ||
| Soleus Capital | PE/Buyout | Minority | ||
| Bosch Ventures | Corporate Venture Capital | Minority | ||
| GHS Investment Management (Canada) Company | Corporation | Minority | ||
| IBM Ventures | Corporate Venture Capital | Minority |
Variantyx FAQs
-
When was Variantyx founded?
Variantyx was founded in 2014.
-
Where is Variantyx headquartered?
Variantyx is headquartered in Framingham, MA.
-
What is the size of Variantyx?
Variantyx has 194 total employees.
-
What industry is Variantyx in?
Variantyx’s primary industry is Biotechnology.
-
Is Variantyx a private or public company?
Variantyx is a Private company.
-
What is the current valuation of Variantyx?
The current valuation of Variantyx is .
-
What is Variantyx’s current revenue?
The current revenue for Variantyx is .
-
How much funding has Variantyx raised over time?
Variantyx has raised $138M.
-
Who are Variantyx’s investors?
Peregrine Ventures, Soleus Capital, Bosch Ventures, GHS Investment Management (Canada) Company, and IBM Ventures are 5 of 11 investors who have invested in Variantyx.
-
Who are Variantyx’s competitors?
Igenomix, BGI Genomics, Caris Life Sciences, Personalis, and Novogene are some of the 19 competitors of Variantyx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
